Literature DB >> 31044346

Comment on "Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients".

Iris K Minichmayr1,2, Markus Zeitlinger3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31044346     DOI： 10.1007/s40262-019-00768-y

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  2 in total

1.  Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Authors:  João A Abrantes; Siv Jönsson; Mats O Karlsson; Elisabet I Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

2.  Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

Authors:  A Broeker; M Nardecchia; K P Klinker; H Derendorf; R O Day; D J Marriott; J E Carland; S L Stocker; S G Wicha
Journal:  Clin Microbiol Infect       Date:  2019-03-11       Impact factor: 8.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.